MAIA Biotechnology annual r&d spending
2021
2022
2023
2024
2025
MAIA Biotechnology R&D Spending Growth & History (MAIA)
MAIA Biotechnology's r&d spending was $14.5M for fiscal 2025.
View full MAIA Biotechnology company overviewMAIA Biotechnology annual r&d spending history
| Fiscal year | Period ended | R&D spending | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $14.5M | $4.5M | +45.34% |
| 2024 | 2024-12-31 | $10.0M | −$1.1M | −9.93% |
| 2023 | 2023-12-31 | $11.1M | $2.2M | +24.39% |
| 2022 | 2022-12-31 | $8.9M | $5.4M | +155.47% |
| 2021 | 2021-12-31 | $3.5M | — | — |
MAIA Biotechnology quarterly r&d spending
Q2.21
Q3.21
Q1.22
Q2.22
Q3.22
Q4.22
Q1.23
Q2.23
Q3.23
Q4.23
Q1.24
Q2.24
Q3.24
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | R&D spending | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | $5.6M | $2.5M | +81.29% |
| Q1 2026 | 2026-03-31 | $3.5M | $327,565 | +10.24% |
| Q4 2025 | 2025-12-31 | $1.9M | −$1.1M | −36.63% |
| Q3 2025 | 2025-09-30 | $6.4M | $3.7M | +138.35% |
| Q2 2025 | 2025-06-30 | $3.1M | $1.1M | +51.58% |
| Q1 2025 | 2025-03-31 | $3.2M | $876,790 | +37.78% |
| Q4 2024 | 2024-12-31 | $3.0M | −$748,289 | −20.13% |
| Q3 2024 | 2024-09-30 | $2.7M | $67,592 | +2.60% |
| Q2 2024 | 2024-06-30 | $2.1M | −$547,082 | −21.05% |
| Q1 2024 | 2024-03-31 | $2.3M | $124,751 | +5.68% |
| Q4 2023 | 2023-12-31 | $3.7M | $1.3M | +55.32% |
| Q3 2023 | 2023-09-30 | $2.6M | $256,424 | +10.94% |
| Q2 2023 | 2023-06-30 | $2.6M | $479,850 | +22.64% |
| Q1 2023 | 2023-03-31 | $2.2M | $118,662 | +5.71% |
| Q4 2022 | 2022-12-31 | $2.4M | — | — |
| Q3 2022 | 2022-09-30 | $2.3M | $1.3M | +116.62% |
| Q2 2022 | 2022-06-30 | $2.1M | $1.5M | +229.12% |
| Q1 2022 | 2022-03-31 | $2.1M | — | — |
| Q3 2021 | 2021-09-30 | $1.1M | — | — |
| Q2 2021 | 2021-06-30 | $643,987 | — | — |
MAIA Biotechnology r&d spending trends
Between the periods ended 2021-12-31 and 2025-12-31, MAIA Biotechnology's r&d spending increased from $3.5M to $14.5M, a change of $11.1M. The latest reported quarter, Q2 2026, shows $5.6M.
About the metric
What research and development spending means
Research and development (R&D) spending covers the costs of creating and improving products, services, software, technologies, and processes. Higher R&D spending may support future innovation, but the amount alone does not show whether those investments will generate returns.
Calculation and source
SEC-reported R&D expense
TickerStat standardizes research and development expense reported in company SEC filings, including the software-specific US-GAAP R&D concept when it is the filer’s primary R&D expense line. It is historical company-reported spending, not an estimate or forecast. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review MAIA Biotechnology source filings ↗